Empower Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Empower Advisory Group's LLY Position: Q2 2026 in Review
Empower Advisory Group increased its Eli Lilly (LLY) stake by 3.2% in Q2 2026, buying an estimated $8.48M and bringing the position to 268,075 shares worth $322M. The position accounts for 0.77% of the portfolio, ranked #27.
Empower Advisory Group first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Empower Advisory Group held 268,075 shares of Eli Lilly worth $322M as of Q2 2026.
- Empower Advisory Group bought 8,303 Eli Lilly shares in Q2 2026, an estimated $8.48M.
- Eli Lilly made up 0.77% of Empower Advisory Group's portfolio in Q2 2026, its #27 holding.
- Empower Advisory Group first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.